Image Credit:Nephro-Urol Mon
Outline
Renal Failure Due to Human Leptospirosis; An Overview
Abstract
Leptospirosis is endemic in tropical and subtropical countries in South-East Asia. Patients are typically young and the disease influences a broad spectrum of mammals, and might lead to the wide variety conditions ranging from acute to chronic. One of the most important complications of leptospirosis is AKI. It is the most important zoonotic diseases caused by contact with either infected water or urine and can be transmitted to new hosts. Manifestation of leptospirosis varies from asymptomatic state in chronic form to symptomatic state, which encompasses fever, renal failure, icterus, and pulmonary hemorrhage in acute forms. Furthermore, AKI in leptospirosis, has many etiologies, and encompasses direct nephrotoxic action of the leptospira, hyperbillirubinemia, rhabdomyolysis, and hypervolemia (this means that this bacteria affects the tuft of the glumrol and also results in prerenal azotemia by the mechanism of hypovolemia). Case fatality rate of acute kidney injury due to leptospirosis is approximately 22%. This review is an attempt to summarize and discuss the current knowledge in the area of epidemiology and pathology of leptospirosis, with the latest therapeutic approach.
Highlights
References
- 1.Bandara M, Ananda M, Wickramage K, Berger E, Agampodi S. Globalization of leptospirosis through travel and migration. Global Health. 2014;10:61. [PubMed ID: 25112368]. https://doi.org/10.1186/s12992-014-0061-0.
- 2.Daher EF, Krasnalhia LSA, Geraldo BSJ. Leptospirosis-associated acute kidney injury. Jornal Brasileiro de Nefrologia. 2010;32(4):408-15.
- 3.Haake DA, Levett PN. Leptospirosis in humans. Curr Top Microbiol Immunol. 2015;387:65-97. [PubMed ID: 25388133]. https://doi.org/10.1007/978-3-662-45059-8_5.
- 4.Herman HS, Mehta S, Cardenas WB, Stewart-Ibarra AM, Finkelstein JL. Micronutrients and Leptospirosis: A Review of the Current Evidence. PLoS Negl Trop Dis. 2016;10(7). e0004652. [PubMed ID: 27387046]. https://doi.org/10.1371/journal.pntd.0004652.
- 5.Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3(12):757-71. [PubMed ID: 14652202].
- 6.Visith S, Kearkiat P. Nephropathy in leptospirosis. J Postgrad Med. 2005;51(3):184-8. [PubMed ID: 16333190].
- 7.Sejvar J, Tangkanakul W, Ratanasang P, Dowell SF, Sangjun N, Bragg S, et al. An outbreak of leptospirosis, Thailand--the importance of the laboratory. Southeast Asian J Trop Med Public Health. 2005;36(2):289-95. [PubMed ID: 15916032].
- 8.Nia A, Alimohammadi A, Habibi R, Shirzadi MR. Spatial and statistical analysis of leptospirosis in Guilan province, Iran. Int Arch Photogrammetr Remote Sens Spatial Inf Sci. 2015;40(1):497.
- 9.Rajabnia R, Ferdosi Shahandashti E, Yaslianifard S, Ghadami E, Kheirandish A, Adhami N. Detection of Leptospira interrogans in plasma and urine samples by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Afr J Microbiol Res. 2015;9(2):135-9. https://doi.org/10.5897/ajmr2014.7157.
- 10.Yang CW. Leptospirosis in Taiwan--an underestimated infectious disease. Chang Gung Med J. 2007;30(2):109-15. [PubMed ID: 17595998].
- 11.Ghasemian R, Shokri M, Makhlough A, Suraki-Azad MA. The course and outcome of renal failure due to human leptospirosis referred to a hospital in North of Iran; A follow-up study. Caspian J Intern Med. 2016;7(1):7-12. [PubMed ID: 26958326].
- 12.Siriwanij T, Suttinont C, Tantawichien T, Chusil S, Kanjanabuch T, Sitprija V. Haemodynamics in leptospirosis: effects of plasmapheresis and continuous venovenous haemofiltration. Nephrology (Carlton). 2005;10(1):1-6. [PubMed ID: 15705173]. https://doi.org/10.1111/j.1440-1797.2005.00332.x.
- 13.Abdulkader RC, Silva MV. The kidney in leptospirosis. Pediatr Nephrol. 2008;23(12):2111-20. [PubMed ID: 18446381]. https://doi.org/10.1007/s00467-008-0811-4.
- 14.Agesilas F, Gey F, Monbrunt A, Combes JC, Llanas B, Schlossmacher P, et al. [Acute leptospirosis in children in Reunion Island: a retrospective review of 16 cases]. Arch Pediatr. 2005;12(9):1344-8. [PubMed ID: 15994067]. https://doi.org/10.1016/j.arcped.2005.04.084.
- 15.Hamir AN, Hanlon CA, Niezgoda M, Rupprecht CE. The prevalence of interstitial nephritis and leptospirosis in 283 raccoons (Procyon lotor) from 5 different sites in the United States. Can Vet J. 2001;42(11):869-71. [PubMed ID: 11708206].
- 16.Monahan AM, Callanan JJ, Nally JE. Review paper: Host-pathogen interactions in the kidney during chronic leptospirosis. Vet Pathol. 2009;46(5):792-9. [PubMed ID: 19429975]. https://doi.org/10.1354/vp.08-VP-0265-N-REV.
- 17.Alian S, Davoudi A, Najafi N, Ghasemian R, Ahangarkani F, Hamdi Z. Clinical and laboratory manifestation and outcome of icterohemorrhagic leptospirosis patients in Northern Iran. Med J Islam Repub Iran. 2015;29:308. [PubMed ID: 26913271].
- 18.Zakeri S, Sepahian N, Afsharpad M, Esfandiari B, Ziapour P, Djadid ND. Molecular epidemiology of leptospirosis in northern Iran by nested polymerase chain reaction/restriction fragment length polymorphism and sequencing methods. Am J Trop Med Hyg. 2010;82(5):899-903. [PubMed ID: 20439973]. https://doi.org/10.4269/ajtmh.2010.09-0721.
- 19.Lopes AA, Costa E, Costa YA, Sacramento E, de Oliveira Junior AR, Lopes MB, et al. Comparative study of the in-hospital case-fatality rate of leptospirosis between pediatric and adult patients of different age groups. Rev Inst Med Trop Sao Paulo. 2004;46(1):19-24. [PubMed ID: 15057329].
- 20.Niwattayakul K, Homvijitkul J, Niwattayakul S, Khow O, Sitprija V. Hypotension, renal failure, and pulmonary complications in leptospirosis. Ren Fail. 2002;24(3):297-305. [PubMed ID: 12166696].
- 21.Daher EF, Lima RS, Silva Junior GB, Silva EC, Karbage NN, Kataoka RS, et al. Clinical presentation of leptospirosis: a retrospective study of 201 patients in a metropolitan city of Brazil. Braz J Infect Dis. 2010;14(1):3-10. [PubMed ID: 20428646].
- 22.Yang CW, Wu MS, Pan MJ. Leptospirosis renal disease. Nephrol Dial Transplant. 2001;16 Suppl 5:73-7. [PubMed ID: 11509689].
- 23.Haake DA, Chao G, Zuerner RL, Barnett JK, Barnett D, Mazel M, et al. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun. 2000;68(4):2276-85. [PubMed ID: 10722630].
- 24.Shah I. Non-oliguric renal failure-a presentation of leptospirosis. Ann Trop Med Parasitol. 2009;103(1):53-6. [PubMed ID: 19173776]. https://doi.org/10.1179/136485909X384947.
- 25.Li Cavoli G, Tortorici C, Bono L, Ferrantelli A, Giammarresi C, Rotolo U. Acute renal failure in Weil's disease. Dialisis y Trasplante. 2013;34(1):33-5. https://doi.org/10.1016/j.dialis.2012.08.003.
- 26.Abdulkader RC. Acute renal failure in leptospirosis. Ren Fail. 1997;19(2):191-8. [PubMed ID: 9101590].
- 27.Shang ES, Summers TA, Haake DA. Molecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun. 1996;64(6):2322-30. [PubMed ID: 8675344].
- 28.Agampodi SB, Matthias MA, Moreno AC, Vinetz JM. Utility of quantitative polymerase chain reaction in leptospirosis diagnosis: association of level of leptospiremia and clinical manifestations in Sri Lanka. Clin Infect Dis. 2012;54(9):1249-55. [PubMed ID: 22354922]. https://doi.org/10.1093/cid/cis035.
- 29.Araujo ER, Seguro AC, Spichler A, Magaldi AJ, Volpini RA, De Brito T. Acute kidney injury in human leptospirosis: an immunohistochemical study with pathophysiological correlation. Virchows Arch. 2010;456(4):367-75. [PubMed ID: 20217429]. https://doi.org/10.1007/s00428-010-0894-8.
- 30.Sitprija V, Losuwanrak K, Kanjanabuch T. Leptospiral nephropathy. Seminars in nephrology. Elsevier; 2003. p. 42-8.
- 31.Arean VM. The pathologic anatomy and pathogenesis of fatal human leptospirosis (Weil's disease). Am J Pathol. 1962;40:393-423. [PubMed ID: 13862141].
- 32.Herath NJ, Kularatne SA, Weerakoon KG, Wazil A, Subasinghe N, Ratnatunga NV. Long term outcome of acute kidney injury due to leptospirosis? A longitudinal study in Sri Lanka. BMC Res Notes. 2014;7:398. [PubMed ID: 24964804]. https://doi.org/10.1186/1756-0500-7-398.
- 33.Kobayashi Y. Clinical observation and treatment of leptospirosis. J Infect Chemother. 2001;7(2):59-68. [PubMed ID: 11455495]. https://doi.org/10.1007/s1015610070059.
- 34.Guidugli F, Castro AA, Atallah AN, Araujo MG. WITHDRAWN. Antibiotics for treating leptospirosis. Cochrane Database Syst Rev. 2010;(1). CD001306. [PubMed ID: 20091518]. https://doi.org/10.1002/14651858.CD001306.pub2.
- 35.Charan J, Saxena D, Mulla S. Prophylaxis and Treatment for Leptospirosis: Where are the Evidences? Nat J Physiol Pharm Pharmacol. 2012;2(2):78. https://doi.org/10.5455/njppp.2012.2.78-83.
- 36.Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W. Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis. Clin Infect Dis. 2003;36(12):1507-13. [PubMed ID: 12802748]. https://doi.org/10.1086/375226.
- 37.WHO. Human leptospirosis: guidance for diagnosis, surveillance and control. 2003.
- 38.Viriyakosol S, Matthias MA, Swancutt MA, Kirkland TN, Vinetz JM. Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect Immun. 2006;74(2):887-95. [PubMed ID: 16428731]. https://doi.org/10.1128/IAI.74.2.887-895.2006.
- 39.Watt G, Padre LP, Tuazon M, Calubaquib C. Limulus lysate positivity and Herxheimer-like reactions in leptospirosis: a placebo-controlled study. J Infect Dis. 1990;162(2):564-7. [PubMed ID: 2197347].
- 40.Friedland JS, Warrell DA. The Jarisch-Herxheimer reaction in leptospirosis: possible pathogenesis and review. Rev Infect Dis. 1991;13(2):207-10. [PubMed ID: 2041950].
- 41.Phu NH, Hien TT, Mai NT, Chau TT, Chuong LV, Loc PP, et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med. 2002;347(12):895-902. [PubMed ID: 12239258]. https://doi.org/10.1056/NEJMoa020074.
- 42.Abdulkader RC, Daher EF, Camargo ED, Spinosa C, da Silva MV. Leptospirosis severity may be associated with the intensity of humoral immune response. Rev Inst Med Trop Sao Paulo. 2002;44(2):79-83. [PubMed ID: 12048544].
- 43.Daher Ede F, Zanetta DM, Abdulkader RC. Pattern of renal function recovery after leptospirosis acute renal failure. Nephron Clin Pract. 2004;98(1):c8-14. [PubMed ID: 15361699]. https://doi.org/10.1159/000079922.
- 44.Kaul DR, Flanders SA, Saint S. Clinical problem-solving. Clear as mud. N Engl J Med. 2005;352(18):1914-8. [PubMed ID: 15872207]. https://doi.org/10.1056/NEJMcps042340.
- 45.Trevejo RT, Rigau-Perez JG, Ashford DA, McClure EM, Jarquin-Gonzalez C, Amador JJ, et al. Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis. 1998;178(5):1457-63. [PubMed ID: 9780268].
- 46.Marotto PC, Nascimento CM, Eluf-Neto J, Marotto MS, Andrade L, Sztajnbok J, et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis. 1999;29(6):1561-3. [PubMed ID: 10585813]. https://doi.org/10.1086/313501.
- 47.Truccolo J, Serais O, Merien F, Perolat P. Following the course of human leptospirosis: evidence of a critical threshold for the vital prognosis using a quantitative PCR assay. FEMS Microbiol Lett. 2001;204(2):317-21. [PubMed ID: 11731142].
- 48.Doudier B, Garcia S, Quennee V, Jarno P, Brouqui P. Prognostic factors associated with severe leptospirosis. Clin Microbiol Infect. 2006;12(4):299-300. [PubMed ID: 16524404]. https://doi.org/10.1111/j.1469-0691.2005.01335.x.
- 49.Khositseth S, Sudjaritjan N, Tananchai P, Ong-ajyuth S, Sitprija V, Thongboonkerd V. Renal magnesium wasting and tubular dysfunction in leptospirosis. Nephrol Dial Transplant. 2008;23(3):952-8. [PubMed ID: 17951309]. https://doi.org/10.1093/ndt/gfm698.
- 50.Esen S, Sunbul M, Leblebicioglu H, Eroglu C, Turan D. Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Med Wkly. 2004;134(23-24):347-52. [PubMed ID: 15318284].
Copyright
Copyright © 2018, Nephro-Urology Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
Similar Articles
Clinical and Laboratory Findings on Complication in Patients With Leptospirosis in Mazandaran Province, Iran
Najafi N, Davoudi AR, Alian S, Ahangarkani F, Asghari E. Clinical and Laboratory Findings on Complication in Patients With Leptospirosis in Mazandaran Province, Iran. Arch Clin Infect Dis. 2015;10(3):e24695. doi: https://doi.org/10.5812/archcid.24695
Epidemiology, Clinical and Laboratory Findings of Pediatric Leptospirosis in Southeastern Turkey
Orhan Ö, Elci H. Epidemiology, Clinical and Laboratory Findings of Pediatric Leptospirosis in Southeastern Turkey. Inn J Pediatr. 2024;34(3):e142968. doi: https://doi.org/10.5812/ijp-142968
Epidemiologic Assessment of Leptospira Serotypes in Caspian Littoral
Mansour Ghanaei F, Fallah MS, Jafarshad R, Joukar F, Honarmand H, et al. Epidemiologic Assessment of Leptospira Serotypes in Caspian Littoral. Arch Clin Infect Dis. 2008;3(3):. doi:
Leptospirosis in the Rural Areas of Guilan Province (2004-2005)
Rahimi F, Vand Yousefi J, Moradi Bidhendi S, Bouzari M. Leptospirosis in the Rural Areas of Guilan Province (2004-2005). J Kermanshah Univ Med Sci. 2007;11(2):e80685. doi:
Evaluation of two Immunodiagnostic Assays (MAT and IFA) for Human Leptospirosis in Gilan province -Iran
Dezfully N, Mehrabian S. Evaluation of two Immunodiagnostic Assays (MAT and IFA) for Human Leptospirosis in Gilan province -Iran. Jundishapur J Microbiol. 2012;5(4):582-584. doi: https://doi.org/10.5812/jjm.4564
- Scopus by DOI: 3
Last Update: 2 weeks ago
- Scopus by Title: 3
Last Update: 2 weeks ago
- Scopus by Title (Ref): 3
Last Update: 2 weeks ago
- CrossRef: 3
Last Update: 4 days ago
- OpenAlex: 4
Last Update: 1 day ago
- OpenCitations: 3
Last Update: 1 day ago
